Rohimah Mohamud received her MSc and PhD degrees in Vaccinology and Immunology from Universiti Sains Malaysia (USM) and Monash University, Australia in 2007 and 2014, respectively. Her expertise includes the identification and functional studies of regulatory T cells and dendritic cells, allergic airway inflammation mouse models, cancer immunology, and the development of rBCG for TB vaccines. She is currently a University Lecturer and Principal Investigator at USM. Her current research is focused on nanoparticles that mediate immune responses in asthma and cancer research both for human and animal models.